Fredun Pharma Financials

BSE: 539730

₹1,470.70

₹-17.60 (-1.18%)

As on 04-Sep-2026 15:58IST

Market cap

₹2,438 Cr

Revenue (TTM)

₹748 Cr

P/E Ratio

55.6

P/B Ratio

8.3

Div. Yield

0 %

Income Statement (₹ Cr)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
Operating Revenue	747.52	635.47	453.82	--	--	--
Total Income	747.52	639.12	456.27	--	--	--
Total Expenditure	637.23	544.56	401.36	--	--	--
EBITDA	110.29	90.91	52.46	--	--	--
Depreciation	10.40	8.25	5.04	--	--	--
EBIT	99.89	82.66	47.42	--	--	--
Interest	41.38	39.32	22.38	--	--	--
Other Income	--	3.66	2.45	--	--	--
Exceptional Items	--	--	--	--	--	--
Profit before Tax	58.51	47.00	27.49	--	--	--
Provision for Tax	14.69	14.38	7.75	--	--	--
Profit after Tax	43.82	32.62	19.74	--	--	--
Minority Interest	--	0.00	0.00	--	--	--
Share of Associate	--	--	--	--	--	--
Consolidated Profit	43.82	32.62	19.74	--	--	--

Liabilities (₹ Cr)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
Shareholder's Funds	278.11	278.11	141.38	--	--	--
Minority Interest	--	0.00	--	--	--	--
Non-Current Liabilities	67.11	67.11	17.93	--	--	--
Current Liabilities	296.86	296.86	328.10	--	--	--
Total Liabilities	642.08	642.08	487.41	--	--	--

Assets (₹ Cr)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
Non-Current Assets	120.27	143.91	60.21	--	--	--
Current Assets	498.17	498.17	427.20	--	--	--
Total Assets	642.08	642.08	487.41	--	--	--
Total Debt*	--	222.40	167.15	--	--	--
Net Current Assets	201.31	201.31	99.11	--	--	--
Contingent Liabilities	--	--	--	--	--	--

Cashflow (₹ Cr)	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
Cash From Operating Activities	--	11.90	-16.60	--	--	--
Cash Flow from Investing Activities	--	-73.59	-6.35	--	--	--
Cash from Financing Activities	--	121.45	26.65	--	--	--
Net Cash Inflow / Outflow	--	59.76	3.70	--	--	--

Financials Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
Adjusted EPS (₹)	67.14	19.87	13.93	--	--	--
Cash EPS (₹)	26.50	24.89	17.49	--	--	--
Adjusted Book Value (₹)	177.38	160.92	99.81	--	--	--
Dividend per Share (₹)	0.02	0.23	0.23	--	--	--
Cash Flow per Share (₹)	--	21.75	-35.15	--	--	--
Free Cash Flow per Share (₹)	--	-185.77	-112.27	--	--	--

Profitability Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
ROCE (%)	--	21.34	16.16	--	--	--
ROE (%)	20.13	16.09	13.96	--	--	--
ROA (%)	7.76	5.78	4.05	--	--	--
EBIT Margin (%)	13.36	13.01	10.45	--	--	--
Net Margin (%)	5.86	5.10	4.33	--	--	--
Cash Profit Margin (%)	--	6.43	5.46	--	--	--

Growth Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
Revenue Growth (%)	--	40.03	--	--	--	--
EBIT Growth (%)	--	74.32	--	--	--	--
Net Profit Growth (%)	89.55	65.26	--	--	--	--
EPS Growth (%)	69.66	42.59	--	--	--	--
Book Value Growth (%)	--	86.87	--	--	--	--

Valuation Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
Price / Earnings	55.63	28.05	15.99	--	--	--
Price / Book Value	8.31	3.46	2.23	--	--	--
Dividend Yield (%)	0.02	0.04	0.10	--	--	--
EV/EBITDA	23.53	11.34	8.70	--	--	--
Close Price (₹)	938.10	557.27	222.85	--	--	--
High Price (₹)	941.67	666.33	341.33	--	--	--
Low Price (₹)	264.67	211.68	211.67	--	--	--
Market Cap (₹ Cr)	2,437.88	914.95	315.68	--	--	--

Solvency Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
Debt to Equity	0.20	0.84	1.18	--	--	--
Short term debt to equity ratio	--	0.53	1.07	--	--	--
Current Ratio	1.68	1.68	1.30	--	--	--
Quick Ratio	0.77	0.77	0.57	--	--	--
Interest Coverage	2.41	2.20	2.23	--	--	--

Operating Efficiency Ratios	TTM	Mar-26	Mar-25	Mar-24	Mar-23	Mar-22
Debtors to sales (%)	12.40	14.59	39.03	--	--	--
Asset Turnover	1.32	1.13	0.93	--	--	--
Receivable days	--	77.49	142.46	--	--	--
Inventory Days	--	146.38	192.94	--	--	--
Payable days	--	93.37	160.10	--	--	--
Cash Conversion Cycle	--	130.49	175.29	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Income Statement (₹ Cr)